Static balance and function in children with cerebral palsy submitted to neuromuscular block will receive BT-A in the lower limbs (triceps surae). The children will then be randomly allocated for either treatment with motor physical therapy combined with NMES on the tibialis anterior or motor physical therapy alone. The Kazon et al. BMC Pediatrics 2012, 12:5
Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the ma...
Lower limb strength training in children with cerebral palsy – a randomized controlled trial protoco...
The aim of this review paper is to consider the application of neuromuscular electrical stimulation ...
Abstract Background The use of botulinum toxin A (BT-A) for the treatment of lower limb spasticity i...
Background Upper limb (UL) deficits in children with unilateral cerebral palsy (uCP) have traditiona...
It is recognized that objective gait analysis is of great value in planning a multilevel botulinum t...
Cerebral Palsy (CP) is characterized by a heterogeneous nature with a variety of problems. Therefore...
Aim To validate a detailed intramuscular needle placement protocol using passive muscle stretching a...
Cerebral palsy (CP), which is the leading cause of motor disability during childhood, can produce se...
Background: Cerebral palsy (CP), which is the leading cause of motor disability during childhood, ca...
Background Upper limb (UL) deficits in children with unilateral cerebral palsy (uCP) have tradition...
Cerebral palsy (CP), which is the leading cause of motor disability during childhood, can produce se...
In the last 2 decades, BTX-A is increasingly being used in the management of spasticity in children ...
Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the ma...
Neuromuscular electrical stimulation (NMES) applied to the triceps surae muscle is claimed to be eff...
Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the ma...
Lower limb strength training in children with cerebral palsy – a randomized controlled trial protoco...
The aim of this review paper is to consider the application of neuromuscular electrical stimulation ...
Abstract Background The use of botulinum toxin A (BT-A) for the treatment of lower limb spasticity i...
Background Upper limb (UL) deficits in children with unilateral cerebral palsy (uCP) have traditiona...
It is recognized that objective gait analysis is of great value in planning a multilevel botulinum t...
Cerebral Palsy (CP) is characterized by a heterogeneous nature with a variety of problems. Therefore...
Aim To validate a detailed intramuscular needle placement protocol using passive muscle stretching a...
Cerebral palsy (CP), which is the leading cause of motor disability during childhood, can produce se...
Background: Cerebral palsy (CP), which is the leading cause of motor disability during childhood, ca...
Background Upper limb (UL) deficits in children with unilateral cerebral palsy (uCP) have tradition...
Cerebral palsy (CP), which is the leading cause of motor disability during childhood, can produce se...
In the last 2 decades, BTX-A is increasingly being used in the management of spasticity in children ...
Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the ma...
Neuromuscular electrical stimulation (NMES) applied to the triceps surae muscle is claimed to be eff...
Botulinum neurotoxin type-A (BoNT-A) has been used in association with other interventions in the ma...
Lower limb strength training in children with cerebral palsy – a randomized controlled trial protoco...
The aim of this review paper is to consider the application of neuromuscular electrical stimulation ...